Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.
2.

Clorgyline and deprenyl attenuate striatal malonate and 3-nitropropionic acid lesions.

Maragos WF, Tillman PA, Chesnut MD, Jakel RJ.

Brain Res. 1999 Jul 10;834(1-2):168-72.

PMID:
10407109
3.
4.
5.

A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo.

Yang L, Sugama S, Mischak RP, Kiaei M, Bizat N, Brouillet E, Joh TH, Beal MF.

Neurobiol Dis. 2004 Nov;17(2):250-9.

PMID:
15474362
6.

Malonate-induced generation of reactive oxygen species in rat striatum depends on dopamine release but not on NMDA receptor activation.

Ferger B, Eberhardt O, Teismann P, de Groote C, Schulz JB.

J Neurochem. 1999 Sep;73(3):1329-32.

9.

Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats.

Pandey M, Borah A, Varghese M, Barman PK, Mohanakumar KP, Usha R.

Neurochem Int. 2009 Nov;55(6):431-7. doi: 10.1016/j.neuint.2009.04.013. Epub 2009 May 4.

PMID:
19410615
10.

Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats.

Guyot MC, Palfi S, Stutzmann JM, Mazière M, Hantraye P, Brouillet E.

Neuroscience. 1997 Nov;81(1):141-9.

PMID:
9300407
11.
12.

Mitochondrial toxin inhibition of [(3)H]dopamine uptake into rat striatal synaptosomes.

Maragos WF, Zhu J, Chesnut MD, Dwoskin LP.

Biochem Pharmacol. 2002 Apr 15;63(8):1499-505.

PMID:
11996892
13.

Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies.

Ouary S, Bizat N, Altairac S, Ménétrat H, Mittoux V, Condé F, Hantraye P, Brouillet E.

Neuroscience. 2000;97(3):521-30.

PMID:
10828534
14.
15.
16.

Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat.

Brouillet E, Guyot MC, Mittoux V, Altairac S, Condé F, Palfi S, Hantraye P.

J Neurochem. 1998 Feb;70(2):794-805.

17.

Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid.

Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT.

J Neurosci. 1993 Oct;13(10):4181-92.

18.

Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production.

Villarán RF, Tomás-Camardiel M, de Pablos RM, Santiago M, Herrera AJ, Navarro A, Machado A, Cano J.

Neurotoxicology. 2008 Mar;29(2):244-58. Epub 2007 Nov 17.

PMID:
18093658
19.

Role of corticostriatal and nigrostriatal inputs in malonate-induced striatal toxicity.

Meldrum A, Dunnett SB, Everitt BJ.

Neuroreport. 2001 Jan 22;12(1):89-93.

PMID:
11201098
20.

Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways.

Lee ST, Chu K, Park JE, Hong NH, Im WS, Kang L, Han Z, Jung KH, Kim MW, Kim M.

J Neurochem. 2008 Mar;104(5):1190-200. Epub 2007 Nov 1.

Supplemental Content

Support Center